Cardio Diagnostics Holdings, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Cardio Diagnostics Holdings, Inc. filed definitive additional materials related to a proxy statement with the SEC.
NASDAQ
Cardio Diagnostics Holdings, Inc. is holding its annual meeting on October 15, 2025, seeking stockholder approval for director elections, a significant future share issuance to raise capital, and auditor ratification.
NASDAQ
Cardio Diagnostics Holdings, Inc. has filed a definitive proxy statement with the U.S. Securities and Exchange Commission.
NASDAQ
Cardio Diagnostics Holdings is holding its annual meeting to vote on key proposals including a reverse stock split, future share issuance, director elections, and auditor ratification.